Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Innohep (tinzaparin sodium) Injection, Bristol-Myers Squibb Pharma Company NDA 20-484/S-002 2/5/02 4/17/02 Innohep (tinzaparin sodium) Injection, Dupont Pharmaceutical Company NDA 20-484 7/14/00 7/24/00 7/24/00 4/9/02 | Innohep Indications: for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium. | Innohep (tinzaparin sodium injection), Pharmion, Labeling Revision | Innohep (tinzaparin sodium) Injection, Celgene Corporation, Labeling Revision | Innohep (tinzaparin sodium) Injection, Celgene Corp., Labeling Revision | Innohep (tinzaparin sodium) Injection, LEO Pharma, Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com